Cargando…

Antioxidant Role in Critically Ill Patients with Vasodilatory Shock: Does Glutathione Peroxidase Correlate to Severity of Tissue Hypoxia and Organ Failure

PURPOSE: We aimed to evaluate the antioxidant role in critically ill patients with vasodilatory shock as it relates to severity of tissue hypoxia and organ failure. PATIENTS AND METHODS: An observational and prospective study was conducted in critically ill patients with vasodilatory shock. Glutathi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Semedi, Bambang Pujo, Rehatta, Nancy Margarita, Nugraha, Jusak, Soetjipto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155716/ https://www.ncbi.nlm.nih.gov/pubmed/37151382 http://dx.doi.org/10.2147/OAEM.S407958

Ejemplares similares

How Effective is Angiotensin II in Decreasing Mortality of Vasodilatory Shock? A Systematic Review
por: Semedi, Bambang Pujo, et al.
Publicado: (2023)

Vasopressin in vasodilatory shock: is the heart in danger?
por: Hauser, Balázs, et al.
Publicado: (2008)

Vasopressin and terlipressin in adult vasodilatory shock
por: Polito, Angelo, et al.
Publicado: (2012)

VASOPRESSOR-RESISTANT HYPOTENSION, COMBINATION VASOPRESSOR THERAPY, AND SHOCK PHENOTYPES IN CRITICALLY ILL ADULTS WITH VASODILATORY SHOCK
por: Priyanka, Priyanka, et al.
Publicado: (2022)

Angiotensin II in vasodilatory shock: lights and shadows
por: Antonucci, Elio, et al.
Publicado: (2017)

Advances in Vasodilatory Shock: A Concise Review
por: Lahiry, Sandeep, et al.
Publicado: (2019)

Prolonged ICU Stay in Severe and Critically-Ill COVID-19 Patients Who Received Convalescent Plasma Therapy
por: Semedi, Bambang Pujo, et al.
Publicado: (2022)

Glutathione peroxidases as oncotargets
por: Jiao, Yang, et al.
Publicado: (2017)

Immunomodulation Effect of Convalescent Plasma Therapy in Severe – Critical COVID-19 Patients
por: Fitriah, Munawaroh, et al.
Publicado: (2023)

Vasopressin in vasodilatory shock: hemodynamic stabilization at the cost of the liver and the kidney?
por: Bracht, Hendrik, et al.
Publicado: (2007)

Risk factors for severe vasodilatory shock after cardiac surgery
por: Almeida, J, et al.
Publicado: (2015)

Angiotensin II: a new therapeutic option for vasodilatory shock
por: Bussard, Rachel L, et al.
Publicado: (2018)

PEGylation and antioxidant effects of a human glutathione peroxidase 1 mutant
por: Zhang, Guang-Yuan, et al.
Publicado: (2022)

Comparison of Effectiveness between Wycope Video Laryngoscope, C-MAC Video Laryngoscope, and Direct Laryngoscope in Intubation of Elective Surgery Patients
por: Jayadi,, et al.
Publicado: (2022)

Vasopressin in pediatric vasodilatory shock: a multicentred randomized controlled trial
por: Choong, K, et al.
Publicado: (2009)

Refractory vasodilatory shock secondary to metformin overdose supported with VA ECMO()
por: Ives Tallman, Crystal, et al.
Publicado: (2021)

STUDY OF TOTAL ANTIOXIDANT STATUS AND GLUTATHIONE PEROXIDASE ACTIVITY IN TUNISIAN VITILIGO PATIENTS
por: Jalel, Akrem, et al.
Publicado: (2009)

Optimal target blood pressure in critically ill adult patients with vasodilatory shock: A systematic review and meta-analysis
por: Yoshimoto, Hidero, et al.
Publicado: (2022)

Expression of glutathione, glutathione peroxidase and glutathione S-transferase pi in canine mammary tumors
por: Leonel, Camila, et al.
Publicado: (2014)

Vasopressin in vasodilatory shock: ensure organ blood flow, but take care of the heart!
por: Dünser, Martin W, et al.
Publicado: (2006)

Vasopressin for the treatment of vasodilatory shock: an ESICM systematic review and a meta-analysis
por: Polito, A, et al.
Publicado: (2011)

Early norepinephrine decreases fluid and ventilatory requirements in pediatric vasodilatory septic shock
por: Ranjit, Suchitra, et al.
Publicado: (2016)

Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
por: Bellomo, Rinaldo, et al.
Publicado: (2020)

Increase of lung function usage bronchoscopy in COVID-19 patients: Three case series in Indonesian adult
por: Muljono, Christa Graziella, et al.
Publicado: (2021)

Phytochemical Study of Tapirira guianensis Leaves Guided by Vasodilatory and Antioxidant Activities
por: Rodrigues, Amélia M. G., et al.
Publicado: (2017)

Prognostic Value of PCO(2) Gap in Adult Septic Shock Patients: A Systematic Review and Meta-Analysis
por: Kriswidyatomo, Prihatma, et al.
Publicado: (2022)

The Roles of Glutathione Peroxidases during Embryo Development
por: Ufer, Christoph, et al.
Publicado: (2011)

Function of glutathione peroxidases in legume root nodules
por: Matamoros, Manuel A., et al.
Publicado: (2015)

Evaluation of Glutathione Peroxidase 4 role in Preeclampsia
por: Peng, Xinguo, et al.
Publicado: (2016)

Antioxidative Stress and Anti-Inflammatory Activity of Fucoidan Nanoparticles against Nephropathy of Streptozotocin-Induced Diabetes in Rats
por: Wardani, Giftania, et al.
Publicado: (2022)

Angiotensin II for the treatment of vasodilatory shock: enough data to consider angiotensin II safe?
por: Buchtele, Nina, et al.
Publicado: (2018)

Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
por: Tumlin, James A., et al.
Publicado: (2018)

Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series
por: Zangrillo, Alberto, et al.
Publicado: (2020)

Gene Expression Scoring of Immune Activity Levels for Precision Use of Hydrocortisone in Vasodilatory Shock
por: Yao, Lijing, et al.
Publicado: (2022)

Methylene blue for vasodilatory shock in the intensive care unit: a retrospective, observational study
por: Naoum, Emily E., et al.
Publicado: (2022)

Optimal target blood pressure in critically ill adult patients with vasodilatory shock: a protocol for a systematic review and meta-analysis
por: Fukui, Satoshi, et al.
Publicado: (2021)

Association between Polymorphisms in Glutathione Peroxidase and Selenoprotein P Genes, Glutathione Peroxidase Activity, HRT Use and Breast Cancer Risk
por: Méplan, Catherine, et al.
Publicado: (2013)

Utilization of Synthetic Human Angiotensin II for Catecholamine-Resistant Vasodilatory Shock in Critically Ill Children: A Single-Center Retrospective Case Series
por: Tezel, Oguzhan, et al.
Publicado: (2023)

"Vasopressor Support Sparing Strategies": a Concept to be Incorporated as a Paradigm in the Treatment of Vasodilatory Shock
por: Evora, Paulo Roberto B., et al.
Publicado: (2019)

Synthetic Human Angiotensin II in Pediatric Patients With Vasodilatory Shock: A Report on Two Patients
por: Bailey, Dwight M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bfnhq99pokep7hka2l2nam17tu